{"schema_version":"secwatch.filing_event.v1","accession":"0000896264-25-000210","form_type":"8-K","ticker":"USNA","cik":"0000896264","company_name":"USANA HEALTH SCIENCES INC","filed_at":"2025-10-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.532894+00:00","generated_at":"2026-05-17T04:17:04.751552+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"USANA preliminary Q3 net loss $6.5M, sales $214M, tax rate spikes to 471%; full-year EPS guidance cut","bullets":["Q3 net sales $214M (up from $200M YoY) but operating earnings fall to $1.2M from $15.6M.","Diluted EPS loss $0.36 ($0.56 profit in Q3 2024); adjusted EPS loss $0.15.","Effective tax rate 471% due to annual rate change from 45% to 65%, adding ~$7.5M in extra tax.","Full-year sales expected at or near lower end of prior range; EPS below previously issued range.","Hiya (DTC) sales softer but still expected to achieve double-digit growth for 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000896264-25-000210","json":"https://secwatch.observer/filing/0000896264-25-000210.json","markdown":"https://secwatch.observer/filing/0000896264-25-000210.md","text":"https://secwatch.observer/filing/0000896264-25-000210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000210/0000896264-25-000210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000210/usna-20251009.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:17:04.751552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}